Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemaris is a global leader in the specialty food ingredients industry, specializing in the production of high-intensity sweeteners and preservatives. Rebranded from Nutrinova in 2024, the company operates as a joint venture between Mitsui & Co. and Celanese, combining extensive chemical expertise with global distribution networks. Chemaris is the primary producer of Sunett (acesulfame potassium) and a leading supplier of sorbic acid and potassium sorbate, which are critical for the food, beverage, and pharmaceutical industries. The company is headquartered in Germany and maintains significant manufacturing operations within the Hoechst Industrial Park in Frankfurt. Its business model focuses on leveraging acetyl-based chemistry to deliver high-purity ingredients that ensure product safety and consumer satisfaction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemaris Acetyls.